12:05 PM EST - Knight Therapeutics Inc. : Announced today acceptance by the Toronto Stock Exchange of the Company's Notice of Intention to Make a Normal Course Issuer Bid. Pursuant to the NCIB, the Company proposes to purchase, from time to time over the next 12 months, if considered advisable, up to 5,999,524 common shares of the Company, being approximately 10% of its public float of 59,995,245 common shares, as of June 30, 2023. Knight Therapeutics Inc.
shares T.GUD are trading up $0.04 at $4.92.
